Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00654004 · ClinicalTrials.gov registry record
Fatty Acid Oxidation Disorders & Body Weight Regulation Grant
A clinical trial of Trifunctional Protein Deficiency, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT00654004: Completed study of Trifunctional Protein Deficiency, sponsored by Oregon Health and Science University.
NCT00654004 is a study of Trifunctional Protein Deficiency that has completed, run by Oregon Health and Science University. The registered enrollment target is 26 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00654004, a study of Trifunctional Protein Deficiency, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Several hormones involved in body weight regulation increase the subject's ability to burn fat for energy. The purpose of this study is to investigate how burning fat for energy may affect those hormones and body weight in children. The study will also determine if eating a diet higher in protein alters the amount of fat you burn and how these hormones control body weight.
Primary Outcome
Body composition by DEXA was measured in subjects with a long-chain fatty acid oxidation disorder (n=13). Twelve age, sex and BMI matched controls and 4 heterozygotes for a long-chain fatty acid oxidation disorder were recruited who also completed body composition measures. The difference in body composition between subjects and age matched controls was compared by t-test.
Conditions Studied
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-04 |
| Est. Completion | 2011-01 |
What the finished NCT00654004 record still lists
NCT00654004 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.
The record links to 1 condition, with Trifunctional Protein Deficiency appearing as the primary indexed condition, and to 0 interventions.
NCT00654004 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT00654004 about?
NCT00654004 is a clinical study titled "Fatty Acid Oxidation Disorders & Body Weight Regulation Grant". Several hormones involved in body weight regulation increase the subject's ability to burn fat for energy. The purpose of this study is to investigate how burning fat for energy may affect those hormones and body weight in children. The study will also determine if eating a diet higher in protein al...
What is the current status of trial NCT00654004?
This trial is currently completed. The enrollment target is 26 participants. The study started on 2006-04. Estimated completion is 2011-01.
What conditions does trial NCT00654004 study?
This clinical trial studies the following conditions: Trifunctional Protein Deficiency.
Who is sponsoring clinical trial NCT00654004?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00654004 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia